Th1 and Th2 lymphocytes in autoimmune disease

Area of Science:

• Immunology
• Autoimmune Diseases

Background:

• The Th1/Th2 paradigm is a framework for understanding T-cell responses in autoimmune diseases.
• Evidence suggests diseases like multiple sclerosis and type 1 diabetes are Th1-mediated.
• However, numerous exceptions challenge the direct application of this paradigm.

Purpose of the Study:

• To re-evaluate the applicability of the Th1/Th2 paradigm in Th1-mediated autoimmune diseases.
• To address discrepancies and exceptions within the Th1/Th2 model.
• To integrate recent findings on T-cell regulation into the understanding of autoimmune disease pathogenesis.

Main Methods:

• Review of existing literature on Th1/Th2 responses in autoimmune diseases.
• Analysis of contradictory findings regarding Th1 cytokine (IFN-gamma) actions.
• Examination of the role of Th2 lymphocytes in disease pathogenesis.
• Inclusion of recent data on innate and adaptive immune regulation of T-cells.

Main Results:

• While some autoimmune diseases align with the Th1/Th2 model, many exceptions exist.
• The pleiotropic effects of IFN-gamma and the pathogenic potential of Th2 cells contribute to these exceptions.
• New understanding of T-cell regulation, including innate immune influences, helps explain discrepancies.

Conclusions:

• The Th1/Th2 paradigm requires nuanced application in Th1-mediated autoimmune diseases.
• Exceptions highlight the complexity of immune responses in autoimmunity.
• The Th1/Th2 concept remains integral but must be considered within a broader regulatory network involving innate immunity and other T-cell subsets.